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 Socio-economic deprivation is associated with increased risk of cardiovascular 
disease in people with diabetes. 
 This study, using a national database of quarter of a million people, found that socio-
economic deprivation is strongly positively associated with smoking and obesity, 
modestly positively associated with above-target HbA1c, and modestly negatively 
associated with above-target cholesterol, with no evidence of an association with 
above-target blood pressure. 
 Inequalities appear to have widened over time. 
 Our findings may enable more effective interventions to reduce these inequalities by 
targeted approaches in subgroups of the population. 
 
Abstract 
Aim To describe the association between socio-economic status and prevalence of key 
cardiovascular risk factors in people with type 2 diabetes in Scotland. 
Methods A cross-sectional study of 264 011 people with type 2 diabetes in Scotland in 2016 
identified from the population-based diabetes register. Socio-economic status was defined 
using quintiles of the area-based Scottish Index of Multiple Deprivation (SIMD) with quintile 
(Q)1 and Q5 used to identify the most- and least-deprived fifths of the population, 
respectively. Logistic regression models adjusted for age, sex, health board, history of 










cardiovascular disease and duration of diabetes were used to estimate odds ratios (ORs) for 
Q1 compared with Q5 for each risk factor. 
Results The mean (SD) age of the study population was 66.7 (12.8) years, 56% were men, 
24% were in Q1 and 15% were in Q5. Crude prevalence in Q1/Q5 was 24%/8.8% for 
smoking, 62%/49% for BMI ≥ 30 kg/m2, 44%/40% for HbA1c ≥ 58 mmol/mol (7.5%), 
31%/31% for systolic blood pressure (SBP) ≥ 140 mmHg, and 24%/25% for total cholesterol 
≥ 5 mmol/l, respectively. 
ORs [95% confidence intervals (CI)] were 3.08 (2.95–3.21) for current smoking, 1.48 (1.44–
1.52) for BMI ≥ 30 kg/m2, 1.11 (1.08–1.15) for HbA1c ≥ 58 mmol/mol (7.5%), 1.03 (1.00–
1.06) for SBP ≥ 140 mmHg and 0.87 (0.84–0.90) for total cholesterol ≥ 5 mmol/l. 
Conclusions Socio-economic deprivation is associated with higher prevalence of smoking, 
BMI ≥ 30 kg/m2 and HbA1c ≥ 58 mmol/mol (7.5%), and lower prevalence of total cholesterol 
≥ 5 mmol/l among people with type 2 diabetes in Scotland. Effective approaches to reducing 




Low socio-economic status is associated with excess risk of cardiovascular disease (CVD), a 
major cause of mortality and morbidity in people with and without diabetes, although 
incidence and mortality are decreasing in many countries [1]. Socio-economic deprivation 
further increases the elevated risk of CVD among people with diabetes compared with people 
without diabetes [2]. Much of the disparity in CVD risk can be explained by the higher 
prevalence of CVD risk factors in people of lower socio-economic status compared with 
people of higher socio-economic status [3,4]. Understanding risk factor patterns among 
people with diabetes is important to address health inequalities [5]. 










Prevalence of type 2 diabetes and incidence of diabetes complications are also inversely 
associated with socio-economic status. Mortality as a result of CVD complications of 
diabetes is higher in more deprived populations [6]. In the USA, these inequalities are largely 
explained by differences in CVD risk factor prevalence and access to and use of healthcare 
services [7]. 
Previous research in Scotland describing socio-economic inequalities in CVD risk factor 
prevalence in people with diabetes includes studies of almost 50 000 people in Glasgow and 
Lothian in 2005–2006 [8], around 10 000 people in Tayside in 2006 [9], and ~ 15 000 people 
in Ayrshire and Arran in 2008–2009 [10]. No previous studies have described the association 
between socio-economic status and CVD risk factor prevalence in people with diabetes 
across the whole of Scotland. In addition, the Quality and Outcomes Framework (QOF), 
which included payment based on performance on clinical and organizational measures 
including those for people with diabetes in Scotland between 2004 and 2017 [11,12], and the 
ban on smoking in public places introduced in 2006 may have affected inequalities in CVD 
risk factor prevalence among people with diabetes. Some evidence indicates that QOF may 
have led to improvements in inequalities in risk factor patterns for chronic diseases [13]. 
However, as people who refused to attend clinics could be excluded from QOF target data, 
and such exclusions were more common in more deprived areas, inequalities may be 
underestimated from QOF data [14]. By contrast, other authors comment that QOF has not 
had a significant effect on health inequalities [15], and that QOF may have contributed to 
widening inequalities [16]. 
The Scottish Index of Multiple Deprivation (SIMD) provides an area-based measure of socio-
economic status. In the 2016 SIMD, Scotland was split into 6976 geographical data zones 
with an average of 760 residents in each zone [17]. SIMD scores were calculated for each 










data zone based on seven domains (current income, employment, health, education, skills and 
training, geographic access to services, crime, and housing) [18]. 
The aim of this study was to describe the association between socio-economic status and 
prevalence of key CVD risk factors in people with type 2 diabetes in contemporary Scottish 
data. 
The specific objectives were to: (1) determine the crude prevalence of CVD and CVD risk 
factors, stratified by SIMD quintile; (2) estimate odds ratios (ORs) for CVD risk factor 
prevalence by individual risk factor and SIMD quintile, adjusted for potential confounders; 
and (3) compare the results with data from previous studies. 
<H1>Participants and methods 
<H2>Design and cohort selection 
A cross-sectional study was performed using a 2016 research extract of the dynamic 
population-based diabetes register in Scotland (Scottish Care Information–Diabetes; SCI-
Diabetes), that had been linked to national hospital admission records (see 
https://www.ndc.scot.nhs.uk/National-Datasets/data.asp?SubID=5 for more detail). The 
diabetes register includes demographic, clinical and laboratory data derived from daily 
downloads of data from all primary care practices and diabetes clinics in hospitals in 
Scotland. Permission for the research was obtained from the Scottish multicentre research 
ethics committee (reference 11/AL/0225) and the Privacy Advisory Committee (reference 
33/11). 
People with diagnosed type 2 diabetes in Scotland who were alive on 30 June 2016 were 
included. We excluded people with missing data for SIMD (0.2%) and people aged 
> 100 years (0.05%), leaving 264 011 individuals in the main analysis. 
<H2>Variables 










socio-economic status was defined using quintiles of SIMD referred to as Q1, Q2, Q3, Q4 
and Q5, where Q1 and Q5 represent the most- and least-deprived fifths of the population, 
respectively. 
CVD risk factors were defined from all records closest to 30 June 2016 as: current smoker, 
obesity (BMI ≥ 30 kg/m2), HbA1c ≥ 58 mmol/mol (7.5%), systolic blood pressure (SBP) 
≥ 140 mmHg and total cholesterol ≥ 5 mmol/l. Extreme values, defined as HbA1c 
< 30 mmol/mol (4.9%), HbA1c >200 mmol/mol (20%), BMI < 15 kg/m2, BMI > 80 kg/m2, 
cholesterol < 2.4 mmol/l, and SBP < 100 mmHg, were removed and treated as missing. No 
risk factor had more than 3.6% missing/implausible values (Fig. S1). 
History of CVD was defined broadly using the International Statistical Classification of 
Diseases and Related Health Problems (ICD)-9 codes 390–459 or ICD-10 codes I00–I99 in 
hospital admission records in Scotland that date back to 1981. 
<H2>Statistical analysis 
R (version 3.5.1) and SPSS (version 24) were used for statistical analysis. 
One-way analysis of variance (ANOVA) tests for trend were used to test for differences 
between quintiles in continuous variables and chi-squared tests for trend were used to test for 
differences between quintiles in categorical variables in the descriptive analysis. Logistic 
regression models were used to generate ORs and 95% confidence intervals (CI) for each 
quintile compared with Q5 for each risk factor, adjusted for age as a continuous variable, sex, 
health board as a categorical variable (with smaller health boards combined to form 10 
categories), history of CVD and duration of diabetes as a continuous variable. Further 
adjustment for BMI as a continuous variable and/or smoking (as current and never/ex-smoker 
categories) was performed for HbA1c. Potential interactions between SIMD and age and sex 
were explored. Adjusted OR stratified by health board were compared with those of previous 
Scottish regional studies. Adjustment factors were: age, sex, history of CVD and health board 










for the Glasgow and Lothian study [8]; age, sex, duration of diabetes and BMI for the 
Tayside study [9]; and age, and BMI for cholesterol ≥ 5 mmol/l with sex stratification for the 
Ayrshire and Arran study [10]. 
<H1>Results 
<H2>Participants and data completeness 
The study cohort included 264 011 people with type 2 diabetes in Scotland who were alive on 
30 June 2016. Figure S1 describes the cohort selection and the distribution of 
missing/implausible data. All available risk factor data were used in the analyses and only 
4.9% of individuals had a missing value for one or more risk factors. Patterns of missing data 
differed slightly by deprivation; 5.3% had one or more risk factor missing in Q1 (the most 
deprived quintile), 4.8% in Q2/Q3/Q4, and 4.4% in Q5 (the least deprived quintile). 
<H2>Descriptive data 
Some 24% (n = 62 384) of the study population were in Q1 and 15% (n = 39 742) were in 
Q5. Characteristics of the study participants by socio-economic status are reported in Table 1. 
Compared with Q5, people in Q1 were younger, included a higher proportion of women, had 
shorter duration of diabetes and were more likely to have a history of hospital admission with 
CVD (P < 0.001 for all characteristics). 
<H2>Main results 
Crude overall prevalence of CVD risk factors was: 16% for smoking, 58% for BMI 
≥ 30 kg/m2, 42% for HbA1c ≥ 58 mmol/mol (7.5%), 32% for SBP ≥ 140 mmHg and 25% for 
total cholesterol ≥5 mmol/l. Crude prevalence of CVD risk factors by SIMD quintile is 
reported in Table 1. Smoking, BMI ≥ 30 kg/m2 and HbA1c ≥ 58 mmol/mol (7.5%) were more 
common among more-deprived populations, and SBP ≥ 140 mmHg and total cholesterol 
≥ 5 mmol/l tended to be more common in the middle socio-economic status quintile groups. 










Adjusted ORs for each risk factor for Q1 compared with Q5 are shown in Fig. 1. ORs (95% 
CI) for Q1 compared with Q5 were 3.08 (2.95–3.21) for current smoking, 1.48 (1.44–1.52) 
for BMI ≥ 30 kg/m2 and 1.11 (1.08–1.15) for HbA1c ≥ 58 mmol/mol (7.5%). For HbA1c 
≥ 58 mmol/mol (7.5%), additional adjustment for BMI and/or smoking had little effect (OR 
between 1.09 and 1.12). By contrast, there was little or no association between socio-
economic status and SBP ≥ 140 mmHg (OR 1.03, 95% CI 1.00–1.06), and there was an 
inverse association with cholesterol ≥ 5 mmol/l (OR 0.87, 95% CI 0.84–0.90). Adjusted ORs 
for each risk factor for Q2, Q3 and Q4 compared with Q5 are shown in Table 2 and show 
approximately linear trends. 
<H2>Interactions 
Figure 2 describes interactions between socio-economic status and age and sex. The main 
interactions are reported below. 
<H3>Age 
Inequalities in HbA1c ≥ 58 mmol/mol (7.5%) appear to be in the reverse direction in the 
group aged ≥ 75 years (Q1 compared with Q5: OR 0.93, 95% CI 0.88–0.98) compared with 
other age groups (P for interaction <0.001) (Fig. 2c). The OR for cholesterol ≥ 5 mmol/l was 
lower in the ≥ 75-year-old age group (0.74, 95% CI 0.69–0.80) compared with other age 
groups (P < 0.001) (Fig. 2e). Inequalities in BMI ≥ 30 kg/m2 appear to increase with 
increasing age (P < 0.001) (Fig. 2b). No other interactions between age and socio-economic 
status were identified (for interaction with current smoking P = 0.953; for SBP ≥ 140 mmHg 
P = 0.736) (Fig. 2a,d). 
<H3>Sex 
Inequalities by socio-economic status in current smoking were larger in females (OR 3.53, 
95% CI 3.29–3.79) compared with males (OR 2.82, 95% CI 2.67–2.98) (P for interaction 
< 0.001) (Fig. 2a), as were inequalities in cholesterol ≥ 5 mmol/l (OR 0.82, 95% CI 0.79–










0.86 and OR 0.91, 95% CI 0.87–0.96, respectively) (P < 0.001) (Fig. 2e). Inequalities by 
socio-economic status in HbA1c ≥ 58 mmol/mol (7.5%) were larger in males (OR 1.15, 95% 
CI 1.11–1.20) compared with females (OR 1.06, 95% CI 1.01–1.11) (P < 0.001) (Fig. 2c), as 
were inequalities in SBP ≥ 140 mmHg (OR 1.04, 95% CI 1.00–1.08 and 1.02, 0.97–1.06 for 
males and females respectively; P = 0.011) (Fig. 2d). There was no evidence of an interaction 
between sex and socio-economic status for BMI ≥ 30 kg/m2 (P = 0.095) (Fig. 2b). 
<H2>Comparisons with previous Scottish studies 
Patterns of inequalities in HbA1c, SBP and BMI appear to have remained stable over time. In 
absolute terms, crude prevalence of BMI ≥ 30 kg/m2 has increased, for example from 48% in 
2005–2006 to 54% in 2016 in Glasgow, and from 54% in 2008–2009 to 59% in 2016 in 
Ayrshire and Arran. The increase in prevalence over time has been similar by socio-
economic status, for example from 51% in 2005–2006 to 59% in 2016 in Q1 and 38% in 
2005–2006, to 44% in 2016 in Q5 in Glasgow, and from 58% in 2008–2009 to 63% in 2016 
in Q1 and 46% in 2008–2009 to 49% in 2016 in Ayrshire and Arran. Data on time trends in 
absolute values for HbA1c and SBP were not directly comparable. 
Smoking prevalence has declined, for example from 24% in 2005–2006 to 19% in 2016 in 
Glasgow, and from 19% in 2008–2009 to 17% in 2016 in Ayrshire and Arran. However, 
inequalities by socio-economic status in prevalence of smoking for the most-deprived 
compared with the least-deprived fifth of the population appear to have widened over time, 
with evidence of differences by sex, as summarized below: 
 Glasgow and Lothian, OR 3.19 (95% CI 2.99–3.41) in this study vs. 2.78 (2.63–3.03) 
in 2005–2006 [8]; 
 Tayside, OR 3.19 (95% CI 2.76–3.69) in this study vs. 2.22 (1.89–2.63) in 2006 [9]; 










 Ayrshire and Arran, OR 2.65 (95% CI 2.16–3.26) in males and 3.16 (2.45–4.07) in 
females in this study vs. 2.07 (1.69–2.54) in males and 2.95 (2.27–3.83) in females in 
2008–2009 [10]. 
Prevalence of cholesterol ≥ 5 mmol/l has remained approximately constant, for example 26% 
in Glasgow in both 2005–2006 and 2016. However, inequalities in prevalence of cholesterol 
≥ 5 mmol/l by socio-economic status appear to have reversed in direction over time, as 
summarized below: 
 Glasgow and Lothian, OR 0.86 (95% CI 0.82–0.91) in this study vs. 1.09 (1.02–1.16) 
in 2005–2006 [8]; 
 Tayside, OR 0.83 (95% CI 0.73–0.94) in this study vs. 1.12 (0.96–1.33) in 2006 [9]. 
<H1>Discussion 
<H2>Principal findings 
Crude prevalence of CVD risk factors remains high among all people with type 2 diabetes in 
Scotland. Socio-economic status continues to be inversely associated with prevalence of 
current smoking, BMI ≥ 30 kg/m2 and HbA1c ≥ 58 mmol/mol (7.5%). No evidence of an 
association was found with SBP ≥140mHg and there was a positive association between 
socio-economic status and total cholesterol ≥ 5 mmol/l. Age and sex were found to 
significantly modify the association between socio-economic status and prevalence of several 
CVD risk factors. Inequalities in smoking prevalence appear to have widened over time. 
Inequalities in prevalence of cholesterol ≥ 5 mmol/l appear to have changed direction over 
time, now favouring those in Q1 compared with Q5. 
<H2>Comparison with previous studies outside Scotland 
The findings of this study in terms of inequalities in glycaemic control by socio-economic 
status are consistent with studies from other countries. Unemployment was associated with 
significantly higher HbA1c than among people who were employed in South Carolina 










(P = 0.036) [19]. Although there was no association between neighbourhood economic 
disadvantage and HbA1c, individuals living in neighbourhoods with high social 
disorganization had higher HbA1c than those living in areas with lower social disorganization 
in North Carolina (P = 0.01) [20]. A Canadian study reported higher mean HbA1c in those 
living in poverty compared with those not living in poverty [60 mmol/mol (7.6%) and 
53 mmol/mol (7.0%) respectively] [21]. These studies all had small sample sizes (358, 424 
and 295 respectively), and enrolled people by convenience sampling, and are therefore likely 
to be underpowered and biased. 
A study from Saudi Arabia (sample size 1111 with random sampling from three different 
cities) reported an OR for HbA1c ≥ 53 mmol/mol (7%) of 4.33 (95% CI 1.23–15.28) in the 
lowest household income category compared with the highest income category [22]. In a 
large (n = 32 638) population-based Spanish study using electronic primary care records and 
adjusting for age and sex, the findings were similar to those in this study; OR for HbA1c 
≥ 53 mmol/mol (7%) 1.19 (95% CI 1.12–1.27) for people with low compared with high 
income [23]. A study in Sweden reported an OR for HbA1c ≥ 42 mmol/mol (6%) of 1.43 
(95% CI 1.15–1.79) for those with low compared with high income [24]. By contrast, a large 
study from China that included 104 hospitals representing all the major geographical regions 
of China reported OR for HbA1c ≥ 53 mmol/mol (7%) of 0.90 (95% CI 0.83–0.98) for the 
lowest compared with the highest income group after adjusting for age, sex, BMI, smoking, 
alcohol consumption, exercise, and diabetes duration [25]. The discrepancy in findings 
between the Chinese study and other studies is possibly because China is in a different phase 
of epidemiological transition [26]. 
Fewer studies have investigated inequalities in other risk factors in people with type 2 
diabetes. Similar to the findings of this study, there was little evidence for inequalities by 
socio-economic status in BP in the previously described studies from South Carolina [19] and 










from Spain [23]. However, the study from China reported that prevalence of BP 
≥ 140/80 mmHg was higher in the lowest compared with the highest income group (OR 1.16, 
95% CI 1.07–1.27) and found no evidence of an association between income and cholesterol 
levels [25]. In contrast to the findings of this study, the Spanish study did not find an 
association between socio-economic status and smoking (OR 0.98, 95% CI 0.88–1.10) in the 
low compared with the high income group, although it did find a positive association between 
socio-economic status and cholesterol levels (LDL cholesterol ≥ 100 mg/dl OR 0.90, 95% CI 
0.85–0.96) in the low- compared with the high-income group [23]. Smoking appears to be 
less strongly associated with socio-economic status in the Spanish population than in 
Scotland: in Spain 20% of the high-income group were current smokers compared with 14% 
of the low-income group, whereas smoking prevalence in Scotland was 8.8% of the highest 
socio-economic group (Q5) and 24% in the lowest socio-economic group (Q1). In contrast to 
our findings of a statistically significant positive association between socio-economic status 
and total cholesterol ≥ 5 mmol/l, the Swedish study found that prevalence of total cholesterol 
> 4.5 mmol/l was similar between income groups (OR 0.98, 95% CI 0.76–1.23 in the low- 
compared with the high-income group) [24]. The Swedish study was much smaller 
(n = 5048) than the current and confidence intervals overlap, and misclassification bias, as 
different cut-points were used, may have contributed to the discrepancy in findings 
<H2>Strengths and limitations 
The strengths of this study include the fact that population-based data were used from over a 
quarter of a million individuals, giving precise estimates of the association between 
deprivation and CVD risk factor prevalence. Previous studies in Scotland have been limited 
to regions and were based on data from a decade or more ago. The updated estimates include 
the effects of subsequent population-based interventions that are likely to have affected risk 
factor prevalence such as the QOF and the 2006 smoking ban. 










Limitations include those arising from potential inaccuracies and missing data or variables in 
population-based registers and the fact that SIMD provides an area-based measure of 
deprivation that may not necessarily apply to individuals. Misclassification bias of both 
socio-economic status and risk factor prevalence may underestimate socio-economic 
inequalities in the prevalence of CVD risk factors among people with diabetes. There is also 
scope for a circular relationship given that SIMD includes a health component, although there 
is little evidence that removing the health component from SIMD markedly affects 
associations with health outcomes [27]. Previous work from our group indicated that 
approximately two-thirds of people with type 2 diabetes in Scotland in January 2016 received 
prescriptions for one or more treatments for diabetes [28]. Further analysis of those data 
showed the proportions receiving treatment in the most- and least-deprived quintiles, 
respectively, were 85% and 83% for anti-hypertensives and 79% and 75% for statins (S. 
McGurnaghan, personal communication, 2019). 
<H2>External validity 
The findings of this study are based on almost all people with diagnosed type 2 diabetes in 
Scotland in June 2016. Data on time trends of smoking and obesity prevalence by SIMD 
quintile in the general Scottish population are available from the Scottish Health Surveys, 
which report that prevalence of smoking in Q1/Q5 was 39%/15% in 2008 (crude OR 3.6) and 
35%/11% in 2016 (crude OR 4.4) [29,30]. These data suggest that a pattern of widening of 
inequalities in smoking prevalence has occurred over time in the general population of 
Scotland, similar to that we report among people with type 2 diabetes. In the general 
population, inequalities in obesity appear to have also widened, whereas they have been 
approximately stable in those with type 2 diabetes [29,30]. Data on other CVD risk factors by 
SIMD quintile are not available from the Scottish Health Surveys. 










Comparison of our findings with those of the previous literature suggest that the pattern of 
associations between socio-economic status and physiological risk factors among people with 
type 2 diabetes in this study are broadly consistent across developed countries with similar 
lifestyles, cultures and healthcare provision/access. The results of the associations between 
socio-economic status and behavioural risk factors such as smoking should not be 
extrapolated given the evidence of differing patterns between countries. 
<H2>Conclusion 
Prevalence of CVD risk factors remains high among people with type 2 diabetes in Scotland. 
Socio-economic deprivation is strongly positively associated with smoking and BMI 
≥ 30 kg/m2, modestly positively associated with HbA1c ≥ 58 mmol/mol (7.5%), and modestly 
negatively associated with cholesterol ≥ 5 mmol/l with no evidence of an association with 
SBP ≥ 140 mmHg. 
Further research should be carried out to investigate whether patterns of lifestyle and 
treatment including both prescription and adherence to medication to lower these risk factors 
are relevant to inequalities in CVD risk among people with diabetes. Effective approaches to 
reduce inequalities are required in addition to reducing prevalence of CVD risk factors across 
the whole population, particularly with regard to smoking cessation and weight management. 
The finding that age and sex modify the effect of socio-economic status could be used to 
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FIGURE 1 Adjusted odds ratios (ORs) and 95% confidence intervals for key cardiovascular 
disease (CVD) risk factors for the most deprived quintile compared with the least deprived 










quintile of people with type 2 diabetes in Scotland in mid-2016. ORs were adjusted for age, 
sex, health board, history of CVD and duration of diabetes. 
FIGURE 2 Adjusted odds ratios (ORs) and 95% confidence intervals (CI) for (a) current 
smoking, (b) BMI ≥ 30  kg/m2, (c) HbA1c ≥ 58 mmol/mol (7.5%), (d) SBP ≥ 140 mmHg and 
€ total cholesterol ≥ 5 mmol/l for Q1 compared with Q5 of people with type 2 diabetes in 
Scotland in mid-2016. ‘All’ indicates the adjusted OR (and 95% CI) for the whole study 
population, which is also represented by the solid vertical line. The dotted line, where 
feasible to fit in the scale, represents the null OR (1.0) for reference. 
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Figure S1. Flow chart showing cohort selection and missing/implausible values. 










Table 1. Characteristics and crude prevalence of cardiovascular disease risk factors among people with type 2 
diabetes in Scotland 
 Socio-economic status (SIMD quintile) 
All 
P-value 
for trend 1 2 3 4 5 
Total, n 62 384 60 026 54 282 47 577 39 742 264 011 – 
Age, years (mean ± 
SD) 













Male, %  53 54 57 58 60 56 < 0.001 
Diabetes duration, 















History of CVD, %  51 51 50 49 47 50 < 0.001 
Current smoker, %  24 19 15 12 8.8 16 < 0.001 
BMI ≥ 30 kg/m2, %  62 60 58 55 49 58 < 0.001 
HbA1C ≥58mmol/mol 
(7.5%), % 
 44 43 42 42 40 42 < 0.001 
SBP ≥ 140 mmHg, %  31 32 32 32 31 32 < 0.001 
Total cholesterol 
≥ 5 mmol/l, % 
 24 24 25 25 25 25 0.089 
 
Characteristics and crude prevalence of cardiovascular disease (CVD) risk factors are shown for people with 
type 2 diabetes in Scotland in mid-2016 with Scottish Index of Multiple Deprivation (SIMD) data available, 
aged ≤ 100 years and with neither missing nor implausible risk factor data. Data re stratified by deprivation 
quintile, with P-values for analysis of variance (ANOVA) tests for trends in the association with SIMD quintile 
in continuous variables and P-values for chi-squared tests for trends in the association with SIMD quintile in 
categorical variables. 
 
Table 2. Adjusted odds ratios (and 95% confidence intervals) for key CVD risk factors for quintiles 1 to 4 
compared with quintile 5 (the least deprived quintile) of people with type 2 diabetes in Scotland in mid-2016.  
 SIMD quintile (compared with quintile 5) 
1 2 3 4 
Current smoker 3.08 (2.95–3.21) 2.28 (2.19–2.38) 1.81 (1.74–1.90) 1.34 (1.28–1.40) 
BMI ≥ 30 kg/m2 1.48 (1.44–1.52) 1.39 (1.36–1.43) 1.33 (1.29–1.37) 1.21 (1.18–1.24) 
HbA1c ≥ 58 mmol/mol (7.5%) 1.11 (1.08–1.15) 1.09 (1.06–1.13) 1.06 (1.03–1.09) 1.07 (1.04–1.10) 
SBP ≥ 140 mmHg 1.03 (1.00–1.06) 1.05 (1.02–1.08) 1.04 (1.01–1.07) 1.05 (1.02–1.08) 
Total cholesterol ≥ 5 mmol/l 0.87 (0.84–0.90) 0.90 (0.87–0.93) 0.96 (0.93–0.99) 0.98 (0.95–1.02) 
Odds ratios were adjusted for age, sex, health board, history of cardiovascular disease and duration of diabetes. 
SIMD, Scottish Index of Multiple Deprivation. 
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